1-3 of 3
Yu Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu, Jian Xu, Bo Zhang, Yu Hu, Chunyan Sun
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5022–5038.
https://doi.org/10.1182/bloodadvances.2023010335
Published: 2024
Includes: Supplemental data
Journal Articles

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Clinical Trials & Observations
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zun-Min Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Ren-Bin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4349–4357.
https://doi.org/10.1182/bloodadvances.2022009168
Published: 2023
Includes: Supplemental data
Journal Articles

Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome

Clinical Trials & Observations
Chunyan Sun, Jian Xu, Bo Zhang, Haifan Huang, Lei Chen, Han Yan, Aoshuang Xu, Fei Zhao, Daijuan Huang, Liqiong Liu, Jian Li, Yu Hu
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2563–2568.
https://doi.org/10.1182/bloodadvances.2020003783
Published: 2021
Includes: Supplemental data